The Dish’s Weekly Biotechnology News Wrap Up – July 22, 2016

This week’s biotechnology news headlines include, India’s drug approvals near record, MilliporeSigma to build $115M Burlington campus, Dr. Alfred G. Knudson the “Mendel of Cancer Genetics” died, China approves use of GSK’s Cervarix, second possible Zika infection is found in Florida, RedHill Biopharma announces research collaboration wins NIH for potential Ebola treatment, scientists mine public genomics database for cancer immunology.

Cell Culture Events


Bioprocess Insights Webinars

The biopharmaceutical industry has developed into a multi-billion dollar market in just 30 years. Making decisions and setting up strategies in a rapidly changing environment can be challenging. The difference between a good and a great decision can have extensive implications for the future of a company. In this environment, knowledge and experience are what make the difference. Good insights about, for example, technical advancements, process economy implications, and sustainability aspects can help improve the individual decisions and strengthen the overall business strategy.

In this webinar series, four renowned subject matter experts will share their insights into four areas of bioprocessing: upstream, vaccines, downstream, and single-use technology. We will present tangible, recently developed data that can help you in developing modern, cost-efficient, and sustainable bioprocesses.

Don’t miss these on demand webinars –


“India’s Drug Approvals Near Record Despite FDA Inspection Blitz,” Bloomberg

“The U.S. Food and Drug Administration has become something of a bogeyman for India’s stock market. An inspection blitz on Indian drug factories that supply to the U.S. helped push the broader index of Indian health-care stocks down by as much as 20 percent earlier this year from its all-time high in 2015 after some top firms received warning letters for failing to meet the regulator’s standards.

If you like this story, please see our blog titled “Cell Culture Media Optimization – It’s about more than just high protein titer

“MilliporeSigma to build $115m Burlington campus,” The Boston Globe

“MilliporeSigma, a German-owned maker of life sciences equipment, will build a $115 million campus in Burlington to serve as its North American headquarters. The 280,000-square-foot facility at 400 Wheeler Road will include offices and a customer collaboration lab and training center, the company said Tuesday. It will be home for 850 employees relocating from several MilliporeSigma buildings in Billerica. The company employs about 250 other workers in Massachusetts, who will remain at their current sites in Bedford and Danvers.”

If you like this story, please see our blog titled “Cool Tool – Clarification using Acoustic Wave Separation offers Advantages including -Continuous Process Solution

“Dr. Alfred G. Knudson, the ‘Mendel of Cancer Genetics,’ Dies at 93,” The New York Times

“Dr. Alfred G. Knudson, who deduced how certain cancers strike a family generation after generation, died on Sunday at his home in Philadelphia. He was 93.”

If you like this story, please see our blog titled “Gene Therapy Strengthened by Recent Successes”

“China approves use of GSK vaccine Cervarix for cervical cancer,” Reuters

“Drugmaker GlaxoSmithKline Plc said on Monday the China Food and Drug Administration (CFDA) has approved its human papillomavirus (HPV) vaccine, Cervarix, for use in the country to help women fight cervical cancer.”

If you like this story, please see our blog titled “Cool Tool – Off the Shelf Optimized CHO Media and Feed

“Second Possible Zika Infection Is Found in Florida,” The New York Times

“Florida health officials are investigating a possible second case of the Zika virus that may have been locally transmitted. The announcement of the case, in Broward County, comes two days after the state said it was investigating a possible homegrown case in Miami-Dade County.”

If you like this story, please see our blog titled “Cell Flask Adapters Can Streamline the Cell Culturing Process

“RedHill Biopharma announces research collaboration with NIH for potential Ebola treatment,” Pharmaceutical Business Review

“RedHill Biopharma signed a research collaboration agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), intended to evaluate RedHill’s proprietary experimental therapy for the treatment of Ebola virus disease.”

If you like this story, please see our blog titled “Cell Culture and Single Cell Passaging of Human Pluripotent Stem Cells Without the Need for ROCK Inhibitor

“SBP scientists mine public genomics database for cancer immunology,” Fierce Biotech

“Scientists at the Sanford Burnham Prebys Medical Discovery Institute have explored a large genomic database, revealing over 100 genetic regions newly annotated to affect the immune response to cancer. The findings may help to refine drugs that target the immune response to advanced cancers, which are currently difficult to treat.”

If you like this story, please see our blog titled “BIO 2016 Annual Convention – Summary of Highlights

Pin It on Pinterest